Journals / Diagnostic and Interventional Radiology / 2017 / Cilt: 23 - Sayı: 2

Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?

Pages
127–132
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

McNemar's test detected no differences concerning the correct classification of incidental tracer uptake between PET/CT and PET/MRI (P = 0.125).CONCLUSIONIn examinations of the head and neck area, incidental tracer uptake cannot be classified more accurately by PET/MRI than by PET/CT.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSE We aimed to investigate the accuracy of 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI) compared with contrast-enhanced 18F-FDG PET/computed tomography (PET/CT) for the characterization of incidental tracer uptake in examina-tions of the head and neck.METHODSA retrospective analysis of 81 oncologic patients who underwent contrast-enhanced 18F-FDG PET/CT and subsequent PET/MRI was performed by two readers for incidental tracer uptake.
📊
Key Findings & Data:On PET/CT, 27 lesions were classified as most likely benign, one as most likely malignant, and 18 as indeterminate; on PET/MRI, 31 lesions were classified as most likely benign, one lesion as most likely malignant, and 14 as indeterminate.
💡
Conclusion & Impact:McNemar's test detected no differences concerning the correct classification of incidental tracer uptake between PET/CT and PET/MRI (P = 0.125).CONCLUSIONIn examinations of the head and neck area, incidental tracer uptake cannot be classified more accurately by PET/MRI than by PET/CT.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

PURPOSE We aimed to investigate the accuracy of 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI) compared with contrast-enhanced 18F-FDG PET/computed tomography (PET/CT) for the characterization of incidental tracer uptake in examina-tions of the head and neck.METHODSA retrospective analysis of 81 oncologic patients who underwent contrast-enhanced 18F-FDG PET/CT and subsequent PET/MRI was performed by two readers for incidental tracer uptake. In a consensus reading, discrepancies were resolved. Each finding was either characterized as most likely benign, most likely malignant, or indeterminate. Using all available clinical information including results from histopathologic sampling and follow-up examinations, an expert reader classified each finding as benign or malignant. McNemar's test was used to compare the perfor-mance of both imaging modalities in characterizing incidental tracer uptake.RESULTSForty-six lesions were detected by both modalities. On PET/CT, 27 lesions were classified as most likely benign, one as most likely malignant, and 18 as indeterminate; on PET/MRI, 31 lesions were classified as most likely benign, one lesion as most likely malignant, and 14 as indeterminate. For-ty-three lesions were benign and one lesion was malignant according to the reference standard. In two lesions, a definite diagnosis was not possible. McNemar's test detected no differences concerning the correct classification of incidental tracer uptake between PET/CT and PET/MRI (P = 0.125).CONCLUSIONIn examinations of the head and neck area, incidental tracer uptake cannot be classified more accurately by PET/MRI than by PET/CT.

🔖

Cite This Article

SCHAARSCHMİDT, B. M., GOMEZ, B., BUCHBENDER, C., GRUENEİSEN, J., NENSA, F., SAWİCKİ, L. M., RUHLMANN, V., WETTER, A., ANTOCH, G., HEUSCH, P. (2017). Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?. Diagnostic and Interventional Radiology, Cilt: 23 - Sayı: 2, 127–132. https://ajindex.com/articles/350040

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Antoch G, Vogt FM, Freudenberg LS, et al. Whole-body dual-modality PET/CT and whole- body MRI for tumor staging in oncology. JAMA 2003; 290:3199-3206. [CrossRef] Antoch G, Saoudi N, Kuehl H, et al. Accuracy of whole-body dual-modality fluorine-18-2-flu- oro-2-deoxy-d-glucose positron emission to- mography and computed tomography (FDG- PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004; 22:4357-4368. [CrossRef] Antoch G, Stattaus J, Nemat AT, et al. Non- small cell lung cancer: dual-modality PET/ CT in preoperative staging. Radiology 2003; 229:526-533. [CrossRef] Rosenbaum SJ, Lind T, Antoch G, et al. False-positive FDG PET uptake-the role of PET/ CT. Eur Radiol 2006; 16:1054-1065. [CrossRef] Wolff K-D, Follmann M, Nast A. The diagnosis and treatment of oral cavity cancer. Dtsch Ärz- tebl Int 2012; 109:829-835. Grégoire V, Lefebvre J-L, Licitra L, Felip E. Squa- mous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guide- lines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21:184-186. [CrossRef] Schaaf WEJ, Patel Z, Retrouvey M, et al. Fre- quency and clinical relevance of PET/CT inci- dentalomas. Abdom Imaging 2014; 39:657- 662. [CrossRef] Wong W-L, Gibson D, Sanghera B, et al. Evalu- ation of normal FDG uptake in palatine tonsil and its potential value for detecting occult head and neck cancers: A PET CT study. Nucl Med Commun 2007; 28:675-680. [CrossRef] Sebro R, Aparici C, Pampaloni M. Frequency and clinical implications of incidental new primary cancers detected on true whole-body 18F-FDG PET/CT studies. Nucl Med Commun 2013; 34:333-339. [CrossRef] Al-Hakami HA, Makis W, Anand S, et al. Head and neck incidentalomas on positron emission tomographic scanning: ignore or investigate? J Otolaryngol 2011; 40:384-390.
  2. Patel A, Perry T, Hunt I, et al. Should we rou- tinely investigate incidental head and neck findings on 18-fluorodeoxyglucose positron emission tomography in patients being staged for non-small cell lung cancer? A retrospective analysis. Thorac Cardiovasc Surg 2015; 63:604- 608. Held P, Breit A. MRI and CT of tumors of the phar- ynx: comparison of the two imaging procedures including fast and ultrafast MR sequences. Eur J Radiol 1994; 18:81-91. [CrossRef] Sigal R, Zagdanski AM, Schwaab G, et al. CT and MR imaging of squamous cell carcinoma of the tongue and floor of the mouth. Radiographics 1996; 16:787-810. [CrossRef] Leslie A, Fyfe E, Guest P, et al. Staging of squamous cell